Regulatory arbitrage
Solvency II to cause regulatory arbitrage in Asia
A two-tier regulatory market could develop across Asian insurance sectors as Solvency II capital requirements for European insurers will cause them to lose out to domestic competition
Regulatory arbitrage worsening, says Lloyds head
Win Bischoff, chair of Lloyds Banking Group, warns of increasing divergence between regulators
The impact of regulation on the global OTC market
Three web seminars – in Hong Kong, London and New York – exploring key changes in international OTC derivatives regulation from a regional perspective
The future for Basel II
With Basel II delayed yet again, will revisions to the capital Accord happen at all? David Rowe says Basel I is the best argument for persevering, but any revisions must address regulatory arbitrage problems and take greater account of the full range of…